Practices that did not meet cost-savings goals in either the first or second performance periods of the Oncology Care Model (OCM) will likely leave the program, said Barbara L. McAneny, MD, president of the American Medical Association.
Practices that did not meet cost-savings goals in either the first or second performance periods of the Oncology Care Model (OCM) will likely leave the program, said Barbara L. McAneny, MD, president of the American Medical Association.
Transcript
With the second performance period results, it is estimated that 65% of Oncology Care Model practices are still not meeting cost-saving goals. Do you anticipate practices will roll off the model?
As the Oncology Care Model was originally designed, if you did not develop cost savings then you were pushed off that particular model. You don’t get to continue. So, those practices that did not make savings the first time and now have not the second time, I think we will lose them from the Oncology Care Model.
The other option for practices is to take 2-sided risk. And that, I believe, is very problematic for practices. For several reasons. The first, and probably the most important is that practices do not have reserves or actuaries on staff who can figure out what the risk is of the patients they’re taking. We have no way to control who walks through our door. We take care of everybody. So, the lack of reserves is something that a state insurance commissioner would not allow an insurance company to do. If you want to set up an insurance company in any state, you have to convince the insurance commissioner that if you have a series of patients that are more expensive than you predicted, that you have the reserves to pay that back.
Practices don’t have the ability to do that. And with the OCM including the entire cost of care, there are so many factors that are outside of the control of the practices, that it’s not surprising to me that most practices have not met their targets. And it’s not surprising to me that most practices are not willing to take that risk for things outside of their control.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More